Wen‐Wei Qiu

2.5k total citations
67 papers, 2.1k citations indexed

About

Wen‐Wei Qiu is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Wen‐Wei Qiu has authored 67 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 18 papers in Oncology and 16 papers in Organic Chemistry. Recurrent topics in Wen‐Wei Qiu's work include Natural product bioactivities and synthesis (12 papers), Bone Metabolism and Diseases (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). Wen‐Wei Qiu is often cited by papers focused on Natural product bioactivities and synthesis (12 papers), Bone Metabolism and Diseases (9 papers) and Drug Transport and Resistance Mechanisms (8 papers). Wen‐Wei Qiu collaborates with scholars based in China, United States and France. Wen‐Wei Qiu's co-authors include Bao‐Liang Song, Jingjie Tang, Wei Qi, Bo-Liang Li, Mingyao Liu, Jiagui Li, Peishan Li, Jie Tang, Fan Yang and Jian Luo and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Molecular Cell.

In The Last Decade

Wen‐Wei Qiu

66 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen‐Wei Qiu China 22 1.2k 405 318 309 298 67 2.1k
Hyae Gyeong Cheon South Korea 29 1.1k 0.9× 509 1.3× 239 0.8× 271 0.9× 191 0.6× 93 2.4k
Hiroyuki Miyachi Japan 28 1.1k 0.9× 665 1.6× 340 1.1× 214 0.7× 171 0.6× 93 2.1k
Susan C. Frost United States 31 2.0k 1.6× 493 1.2× 161 0.5× 337 1.1× 254 0.9× 61 2.8k
Manoj Kumar Bhat India 29 1.2k 1.0× 242 0.6× 605 1.9× 247 0.8× 636 2.1× 56 2.3k
Aaron B. Miller United States 26 1.5k 1.2× 543 1.3× 485 1.5× 216 0.7× 193 0.6× 47 2.8k
Ladislav Mirossay Slovakia 22 877 0.7× 326 0.8× 375 1.2× 122 0.4× 172 0.6× 79 2.0k
Stefania Bulotta Italy 27 1.0k 0.8× 360 0.9× 245 0.8× 211 0.7× 264 0.9× 60 2.4k
Karuppaiyah Selvendiran United States 35 1.8k 1.5× 255 0.6× 687 2.2× 173 0.6× 854 2.9× 67 3.1k
Julian J. Adams Australia 19 918 0.7× 268 0.7× 179 0.6× 227 0.7× 129 0.4× 32 1.7k
Scott A. Biller United States 27 1.5k 1.2× 830 2.0× 262 0.8× 477 1.5× 411 1.4× 53 2.8k

Countries citing papers authored by Wen‐Wei Qiu

Since Specialization
Citations

This map shows the geographic impact of Wen‐Wei Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Wei Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Wei Qiu more than expected).

Fields of papers citing papers by Wen‐Wei Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Wei Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Wei Qiu. The network helps show where Wen‐Wei Qiu may publish in the future.

Co-authorship network of co-authors of Wen‐Wei Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Wei Qiu. A scholar is included among the top collaborators of Wen‐Wei Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Wei Qiu. Wen‐Wei Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yuxin, et al.. (2025). Synthesis and Biological Evaluation of Heterocycle-Fused Pyxinol Derivatives as Anti-osteoporosis Agents. Journal of Medicinal Chemistry. 68(23). 25229–25254.
2.
Wang, Z.B., et al.. (2024). Hard transparent nanogradient coating for ultradurable omniphobic liquid-like surface. Chemical Engineering Journal. 497. 154415–154415. 3 indexed citations
3.
Zhang, Min, et al.. (2024). Synthesis and antibacterial activities of heterocyclic ring-fused 20(S)-protopanaxadiol derivatives. Bioorganic & Medicinal Chemistry. 112. 117901–117901. 3 indexed citations
4.
Liu, Yuanbin, Liming He, Wenjun Luo, et al.. (2024). A sterol analog inhibits hedgehog pathway by blocking cholesterylation of smoothened. Cell chemical biology. 31(7). 1264–1276.e7. 3 indexed citations
5.
Wang, Dongmei, Meiyao Meng, Jin Qiu, et al.. (2024). FOXA3 regulates cholesterol metabolism to compensate for low uptake during the progression of lung adenocarcinoma. PLoS Biology. 22(5). e3002621–e3002621. 1 indexed citations
6.
Hu, Ao, Jie Wang, Chenchen Li, et al.. (2022). Cholesterylation of Smoothened is a calcium-accelerated autoreaction involving an intramolecular ester intermediate. Cell Research. 32(3). 288–301. 26 indexed citations
7.
Li, Chenchen, et al.. (2022). Synthesis of plant-derived cholesterol from bisnoralcohol. Steroids. 178. 108967–108967. 1 indexed citations
8.
Jiang, Shi‐You, Guoqiang Li, Chenchen Li, et al.. (2022). Synthesis of heterocyclic ring-fused analogs of HMG499 as novel degraders of HMG-CoA reductase that lower cholesterol. European Journal of Medicinal Chemistry. 236. 114323–114323. 16 indexed citations
9.
Yin, Xuan, Jie Wang, Ying Miao, et al.. (2021). Targeting STAT3 by a small molecule suppresses pancreatic cancer progression. Oncogene. 40(8). 1440–1457. 59 indexed citations
10.
Wang, Jie, et al.. (2020). Synthesis of ursodeoxycholic acid from plant-source (20S)-21-hydroxy-20-methylpregn-4-en-3-one. Steroids. 157. 108600–108600. 14 indexed citations
11.
Wang, Jinhua, Yingying Wang, Yundong He, et al.. (2019). A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 422–422. 21 indexed citations
12.
Xie, Jia, Liting Wang, Fan Yang, et al.. (2019). Synthesis and biological evaluation of methylpyrimidine-fused tricyclic diterpene analogs as novel oral anti-late-onset hypogonadism agents. European Journal of Medicinal Chemistry. 176. 21–40. 7 indexed citations
13.
Jiang, Shi‐You, Hui Li, Jingjie Tang, et al.. (2018). Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol. Nature Communications. 9(1). 5138–5138. 131 indexed citations
14.
He, Xiaolong, et al.. (2018). A facile synthesis of ursodeoxycholic acid and obeticholic acid from cholic acid. Steroids. 140. 173–178. 18 indexed citations
15.
Li, Jing, Jing Ji, Yang Bai, et al.. (2017). SH479, a Betulinic Acid Derivative, Ameliorates Experimental Autoimmune Encephalomyelitis by Regulating the T Helper 17/Regulatory T Cell Balance. Molecular Pharmacology. 91(5). 464–474. 11 indexed citations
16.
Chen, Shijie, Yang Bai, Zhen Li, et al.. (2016). A betulinic acid derivative SH479 inhibits collagen-induced arthritis by modulating T cell differentiation and cytokine balance. Biochemical Pharmacology. 126. 69–78. 19 indexed citations
17.
Wang, Yingying, Yuanxue Gao, Wei Gao, et al.. (2015). Design, synthesis and biological evaluation of tricyclic diterpene derivatives as novel neuroprotective agents against ischemic brain injury. European Journal of Medicinal Chemistry. 103. 396–408. 7 indexed citations
18.
He, Haibing, Lixin Gao, Wei-Ping Ma, et al.. (2012). Synthesis and biological evaluation of 4,4-dimethyl lithocholic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B. Bioorganic & Medicinal Chemistry Letters. 22(23). 7237–7242. 16 indexed citations
19.
Tang, Jingjie, Jiagui Li, Wei Qi, et al.. (2011). Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic Plaques. Cell Metabolism. 13(1). 44–56. 331 indexed citations
20.
Qiu, Wen‐Wei, Jie Xu, Xin Li, et al.. (2009). Design and Synthesis of Matrix Metalloprotease Photoaffinity Trimodular Probes. Chinese Journal of Chemistry. 27(4). 825–833. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026